Gamma Biologicals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gamma Biologicals

GBL 24.34

-2.6%

Oct 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: A. Reader who wrote (14)	8/13/1997 8:33:00 AM
From: A. Reader	of 44

HOUSTON--(BUSINESS WIRE)--August 11, 1997--Gamma Biologicals Inc. (AMEX:GBL) announced today that the board of directors declared a 2 1/2 cent-per-share dividend payable October 21, 1997, to shareholders of record on October 6, 1997. Gamma Biologicals manufactures and sells a wide variety of highly refined and specialized testing products known as in-vitro diagnostic reagents. The company markets to blood donation centers (commonly called "blood banks"), transfusion departments of hospitals, medical laboratories and research institutions through a direct sales force and a distributor network. Gamma distributes its products to more than 50 countries. The company's common stock trades on the American Stock Exchange using the symbol GBL. Information about the company is available at www.gammabio.com .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next